第 1 到 73 筆結果,共 73 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2024 | Complete response to front-line therapies is associated with long-term survival in HIV-related lymphomas in Taiwan | WEI-LI MA ; WANG-DA LIU ; HSIN-YUN SUN ; WANG-HUEI SHENG ; SZU-MIN HSIEH ; SHANG-JU WU ; CHIEN-CHING HUNG | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | |||
2 | 2024 | Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies | Wu, Tzong-Yow; Tsai, Wan-Ting; Chen, Kai-Hsiang; Huang, Szu-Ting; Huang, Chun-Fu; Kuo, Po-Hsien; MING-JUI TSAI ; WANG-DA LIU ; KUAN-YIN LIN ; YU-SHAN HUANG ; ARISTINE CHENG ; PAO-YU CHEN ; HSIN-YUN SUN ; HUAI-HSUAN HUANG ; TAI-CHUNG HUANG ; SHANG-JU WU ; MING YAO ; JANN-TAY WANG ; WANG-HUEI SHENG ; CHIEN-CHING HUNG ; YEE-CHUN CHEN ; SHAN-CHWEN CHANG | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | |||
3 | 2024 | Glofitamab as a salvage treatment for B-cell lymphomas in the real world: A multicenter study in Taiwan | Hsu, Ya-Ting; SHANG-JU WU ; Kao, Hsiao-Wen; Hsiao, Sheng-Yen; Liao, Chun-Kai; Chen, Tsai-Yun; Wang, Ming-Chung | Cancer | |||
4 | 2024 | Improved outcomes of localized diffuse large B-cell lymphoma at the Waldeyer ring in comparison to the sinonasal area in the rituximab era | WEI-LI MA ; RUEY-LONG HONG ; PEI-JEN LOU ; MING YAO ; SHANG-JU WU ; CHUNG-WU LIN ; CHUN-WEI WANG ; Chang, Chin-Hao; ANN-LII CHENG ; SUNG-HSIN KUO | Cancer medicine | 0 | 0 | |
5 | 2023 | Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies | Song, Yuqin; SHANG-JU WU ; Shen, Zhixiang; Zhao, Donglu; Chan, Thomas Sau Yan; Huang, Huiqiang; Qiu, Lugui; Li, Jianyong; Tan, Tran-der; Zhu, Jun; Song, Yongping; Huang, Wei-Han; Zhao, Weili; Liu, Herman Sung Yu; Xu, Wei; Chen, Naizhi; Ma, Jun; Chang, Cheng-Shyong; Tse, Eric Wai Choi | Experimental hematology & oncology | 1 | ||
6 | 2023 | Updated quality of life data from the phase 3b VENICE II trial: patients with relapsed or refractory chronic lymphocytic leukemia receiving venetoclax monotherapy | Cochrane, Tara; Enrico, Alicia; Gomez-Almaguer, David; Hadjiev, Evgueniy; Lech-Maranda, Ewa; Masszi, Tamas; Nikitin, Eugene; Robak, Tadeusz; Weinkove, Robert; SHANG-JU WU ; Manzoor, Beenish S; Busman, Todd; Pai, Madhavi; Komlosi, Viktor; Anderson, Mary Ann | Leukemia & lymphoma | |||
7 | 2023 | Immunotherapeutic potential of blinatumomab-secreting γ9δ2 T Cells | SHANG-JU WU ; Lin, Chien-Ting; Liao, Cheng Hao; Lin, Chun-Ming | Translational oncology | 1 | 1 | |
8 | 2022 | Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Dickinson, Michael J; Carlo-Stella, Carmelo; Morschhauser, Franck; Bachy, Emmanuel; Corradini, Paolo; Iacoboni, Gloria; Khan, Cyrus; Wróbel, Tomasz; Offner, Fritz; Trněný, Marek; SHANG-JU WU ; Cartron, Guillaume; Hertzberg, Mark; Sureda, Anna; Perez-Callejo, David; Lundberg, Linda; Relf, James; Dixon, Mark; Clark, Emma; Humphrey, Kathryn; Hutchings, Martin | The New England journal of medicine | 129 | 80 | |
9 | 2022 | Cerebrospinal fluid soluble programmed death-ligand 1 is a useful prognostic biomarker in primary central nervous system lymphoma | Chieh-Lung Cheng ; CHI-YUAN YAO ; Huang, Po-Hao; CHIH-WEI YU ; Fang, Wei-Quan; Chuang, Wen-Hui; SHANG-JU WU ; YU-JEN LIN ; Hung, Yu-Chin; Tsai, Cheng-Hong; SHAN-CHI YU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | British journal of haematology | 0 | 0 | |
10 | 2022 | Distinct Immunogenetic Profiles of Chronic Lymphocytic Leukemia in Asia: A Taiwan Cooperative Oncology Group Registry Study | CHI-YUAN YAO ; Agathangelidis, Andreas; Chuang, Shih-Sung; Tsou, Hsiao-Hui; Feng, Wei-Lien; Liu, Ta-Chih; Chen, Tsai-Yun; Yu, Yuan-Bin; Yeh, Su-Peng; MING YAO ; Wang, Chuan-Cheng; Lin, Johnson; Hwang, Wen-Li; Gau, Jyh-Pyng; WEN-CHIEN CHOU ; Chao, Tsu-Yi; LIANG-IN LIN ; HWEI-FANG TIEN ; Ghia, Paolo; SHANG-JU WU | HemaSphere | 2 | 1 | |
11 | 2022 | Specific refraction-index increments of oxygenated hemoglobin from thalassemia-minor patients are not significantly different than those from healthy individuals | Huang, Shin-Shyang; Lin, Yang-Hsien; SHANG-JU WU ; KUNG-BIN SUNG | Applied optics | 0 | 0 | |
12 | 2022 | Functional association of NR4A3 downregulation with impaired differentiation in myeloid leukemogenesis | Lin, Shih-Chiang; CHI-YUAN YAO ; Hsu, Cheng-An; Lin, Chien-Ting; Calkins, Marcus J; Kuo, Yuan-Yeh; JIH-LUH TANG ; HWEI-FANG TIEN ; SHANG-JU WU | Annals of hematology | 2 | 1 | |
13 | 2022 | Molecular Basis and Role of Siglec-7 Ligand Expression on Chronic Lymphocytic Leukemia B Cells | Chang, Lan-Yi; Liang, Suh-Yuen; Lu, Shao-Chia; Tseng, Huan Chuan; Tsai, Ho-Yang; Tang, Chin-Ju; Sugata, Marcelia; Chen, Yi-Ju; Chen, Yu-Ju; SHANG-JU WU ; Lin, Kuo-I; Khoo, Kay-Hooi; Angata, Takashi | Frontiers in immunology | 18 | 14 | |
14 | 2022 | Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients | Huang, Shang-Yi; Lin, Hsiu-Hsia; MING YAO ; JIH-LUH TANG ; SHANG-JU WU ; WEN-CHIEN CHOU ; SZU-CHUN HSU ; BOR-SHENG KO ; HWEI-FANG TIEN | Journal of the Formosan Medical Association = Taiwan yi zhi | 1 | 0 | |
15 | 2022 | Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial | Cochrane, Tara; Enrico, Alicia; Gomez-Almaguer, David; Hadjiev, Evgueniy; Lech-Maranda, Ewa; Masszi, Tamas; Nikitin, Eugene; Robak, Tadeusz; Weinkove, Robert; SHANG-JU WU ; Sail, Kavita R; Pesko, John; Pai, Madhavi; Komlosi, Viktor; Anderson, Mary Ann | Leukemia & lymphoma | 7 | 5 | |
16 | 2022 | Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience | Wang, Yu-Wen; Tsai, Cheng-Hong ; HSIN-AN HOU ; FENG-MING TIEN ; JIA-HAU LIU ; WEN-CHIEN CHOU ; BOR-SHENG KO ; Chen, Yu-Wen; CHIEN-CHIN LIN ; Chieh-Lung Cheng ; Lo, Min-Yen; YUN-CHU LIN ; LI-CHUN LU ; SHANG-JU WU ; SUNG-HSIN KUO ; RUEY-LONG HONG ; TAI-CHUNG HUANG ; MING YAO | Annals of hematology | 11 | 9 | |
17 | 2022 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | FENG-MING TIEN ; CHENG-HONG TSAI ; Huang, Sheng-Chuan; JIA-HAU LIU ; Chen, Chien-Yuan ; YUAN-YEH KUO ; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; CHIA-WEN LIU ; Liao, Xiu-Wen; LIANG-IN LIN ; Wu, Yu-Sin; Hou, Mei-Fang; SHANG-JU WU ; SZU-CHUN HSU ; BOR-SHENG KO ; WEN-CHIEN CHOU ; MING YAO ; HSIN-AN HOU ; JIH-LUH TANG ; HWEI-FANG TIEN | Bone marrow transplantation | 6 | 6 | |
18 | 2022 | Phosphoproteomics Reveals the Role of Constitutive KAP1 Phosphorylation by B-cell Receptor Signaling in Chronic Lymphocytic Leukemia | Wu, Jung-Lin; Hsin-Yi Wu; SHANG-JU WU ; Tsai, Ho-Yang; Weng, Shao-Hsing; Lin, Kuen-Tyng; LIANG-IN LIN ; CHI-YUAN YAO ; Zamanova, Margarita; Lee, Yi-Yuan; Angata, Takashi; HWEI-FANG TIEN ; Chen, Yu-Ju; Lin, Kuo-I | Molecular cancer research : MCR | 1 | 0 | |
19 | 2021 | Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations | Wierda, William G; Rawstron, Andrew; Cymbalista, Florence; Badoux, Xavier; Rossi, Davide; Brown, Jennifer R; Egle, Alexander; Abello, Virginia; Cervera Ceballos, Eduardo; Herishanu, Yair; Mulligan, Stephen P; Niemann, Carsten U; Diong, Colin P; Soysal, Teoman; Suzuki, Ritsuro; Tran, Hoa T T; SHANG-JU WU ; Owen, Carolyn; Stilgenbauer, Stephan; Ghia, Paolo; Hillmen, Peter | Leukemia | 40 | 34 | |
20 | 2019 | Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 29 | 26 | |
21 | 2019 | Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome | HUAI-HSUAN HUANG ; Chen F.-Y.; WEN-CHIEN CHOU ; HSIN-AN HOU ; BOR-SHENG KO ; Lin C.-T.; JIH-LUH TANG ; Li C.-C.; MING YAO ; WOEI TSAY ; SZU-CHUN HSU ; SHANG-JU WU ; Chen, Chien-Yuan ; SHANG-YI HUANG ; Tseng M.-H.; HWEI-FANG TIEN ; Chen R.-H. | BMC Cancer | 41 | 34 | |
22 | 2019 | Distinctive incidence patterns of follicular lymphoma in Taiwan: Implications of ethnic differences | SHANG-JU WU ; Chen Y.-C.; Lo W.-C.; CHUN-JU CHIANG ; Lin C.-T.; Chuang S.-S.; Lai M.-S. | Cancer Medicine | 4 | 4 | |
23 | 2019 | Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 10 | 9 | |
24 | 2018 | Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome | BOR-SHENG KO ; Wang, Yu-Fen; Li, Jeng-Lin; Li, Chi-Cheng; Weng, Pei-Fang; SZU-CHUN HSU ; HSIN-AN HOU ; HUAI-HSUAN HUANG ; MING YAO ; Lin, Chien-Ting; JIA-HAU LIU ; CHENG-HONG TSAI ; TAI-CHUNG HUANG ; SHANG-JU WU ; SHANG-YI HUANG ; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; Lee, Chi-Chun; JIH-LUH TANG | EBioMedicine | 52 | 45 | |
25 | 2018 | Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients | FENG-MING TIEN ; HSIN-AN HOU ; CHENG-HONG TSAI ; JIH-LUH TANG ; Chen, Chien-Yuan ; Kuo, Yuan-Yeh; Li, Chi-Cheng; Lin, Chien-Ting; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; Tseng, Mei-Hsuan; Liu, Ming-Chih; Liu, Chia-Wen; LIANG-IN LIN ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | European Journal of Haematology | 29 | 23 | |
26 | 2018 | Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome | MING-EN LIN ; HSIN-AN HOU ; CHENG-HONG TSAI ; SHANG-JU WU ; Kuo Y.-Y.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; WEN-CHIEN CHOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; Li C.-C.; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Lin C.-T.; HWEI-FANG TIEN | Clinical Epigenetics | 31 | 25 | |
27 | 2018 | Concerted mass spectrometry-based glycomic approach for precision mapping of sulfo sialylated N-glycans on human peripheral blood mononuclear cells and lymphocytes | Chen J.-Y.; Huang H.-H.; Yu S.-Y.; SHANG-JU WU ; Kannagi R.; Khoo K.-H. | Glycobiology | 18 | 15 | |
28 | 2018 | Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial | Lin C.-T.; PO-REN HSUEH ; SHANG-JU WU ; MING YAO ; BOR-SHENG KO ; Li C.-C.; Hsu C.-A.; JIH-LUH TANG ; HWEI-FANG TIEN | Biology of Blood and Marrow Transplantation | 4 | 3 | |
29 | 2018 | GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia | FENG-MING TIEN ; HSIN-AN HOU ; CHENG-HONG TSAI ; JIH-LUH TANG ; Chiu, Yu-Chiao; Chen, Chien-Yuan ; Kuo, Yuan-Yeh; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; LIANG-IN LIN ; Lin, Chien-Ting; SHANG-JU WU ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-YI HUANG ; MING YAO ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Blood Cancer Journal | 29 | ||
30 | 2018 | Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study | Gambacorti-Passerini C.; Orlov S.; Zhang L.; Braiteh F.; Huang H.; Esaki T.; Horibe K.; Ahn J.-S.; Beck J.T.; Edenfield W.J.; Shi Y.; Taylor M.; Tamura K.; Van Tine B.A.; SHANG-JU WU ; Paolini J.; Selaru P.; Kim T.M. | American Journal of Hematology | 75 | 63 | |
31 | 2017 | Distinct molecular genetics of chronic lymphocytic leukemia in Taiwan: Clinical and pathogenetic implications | SHANG-JU WU ; Lin C.-T.; Agathangelidis A.; LIANG-IN LIN ; Kuo Y.-Y.; HWEI-FANG TIEN ; Ghia P. | Haematologica | 24 | 21 | |
32 | 2017 | Morphometric analysis of erythrocytes from patients with thalassemia using tomographic diffractive microscopy | Lin Y.-H.; Huang S.-S.; SHANG-JU WU ; Sung K.-B. | Journal of Biomedical Optics | 3 | 3 | |
33 | 2016 | Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS) | CHI-YUAN YAO ; HSIN-AN HOU ; Lin, Tzung-Yi; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Tseng, Mei-Hsuan; Chiang, Ying-Chieh; Liu, Ming-Chih; Liu, Chia-Wen; Kuo, Yuan-Yeh; SHANG-JU WU ; Liao, Xiu-Wen; Lin, Chien-Ting; BOR-SHENG KO ; Chen, Chien-Yuan ; SZU-CHUN HSU ; Li, Chi-Cheng; SHANG-YI HUANG ; MING YAO ; JIH-LUH TANG ; WOEI TSAY ; Liu, Chieh-Yu; HWEI-FANG TIEN | Oncotarget | 19 | 18 | |
34 | 2016 | Genetic alterations and their clinical implications in older patients with acute myeloid leukemia | CHENG-HONG TSAI ; HSIN-AN HOU ; JIH-LUH TANG ; Liu, C.-Y.; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Tseng, M.-H.; Chiang, Y.-C.; Kuo, Y.-Y.; Liu, M.-C.; Liu, C.-W.; LIANG-IN LIN ; WOEI TSAY ; MING YAO ; Li, C.-C.; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Chien-Yuan ; Lin, C.-T.; SHANG-JU WU ; HWEI-FANG TIEN | Leukemia | 101 | 90 | |
35 | 2016 | Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation | YUN CHIANG ; CHENG-HONG TSAI ; SUNG-HSIN KUO ; Liu, Chieh-Yu; MING YAO ; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; Lin, Chien-Ting; HSIN-AN HOU ; WEN-CHIEN CHOU ; JIA-HAU LIU ; CHIEN-CHIN LIN ; SHANG-JU WU ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Lin, Kai-Hsin; Lin, Dong-Tsamn; Chou, Hsien-Tang; Lu, Meng-Yu; YUNG-LI YANG ; HSIU-HAO CHANG ; Liu, Ming-Chih; Liao, Xiu-Wen; Wu, Jian-Kuen; SHENG-CHIEH CHOU ; Chieh-Lung Cheng ; Chen, Chien-Yuan ; WOEI TSAY ; HWEI-FANG TIEN ; JIH-LUH TANG ; YU-HSUAN CHEN | Scientific Reports | 18 | 15 | |
36 | 2016 | Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia | HSIN-AN HOU ; Liu, Chieh-Yu; Kuo, Yuan-Yeh; WEN-CHIEN CHOU ; CHENG-HONG TSAI ; CHIEN-CHIN LIN ; LIANG-IN LIN ; Tseng, Mei-Hsuan; Chiang, Ying-Chieh; Liu, Ming-Chih; Liu, Chia-Wen; JIH-LUH TANG ; MING YAO ; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Chien-Yuan ; Lin, Chien-Ting; SHANG-JU WU ; WOEI TSAY ; HWEI-FANG TIEN | Oncotarget | 67 | 62 | |
37 | 2016 | Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Hepatology | 35 | 31 | |
38 | 2015 | TP53 mutations in de novo acute myeloid leukemia patients: Longitudinal follow-ups show the mutation is stable during disease evolution | HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo, Y.-Y.; Liu, C.-Y.; LIANG-IN LIN ; Tseng, M.-H.; Chiang, Y.-C.; Liu, M.-C.; Liu, C.-W.; JIH-LUH TANG ; MING YAO ; Li, C.-C.; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Chien-Yuan ; Lin, C.-T.; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood Cancer Journal | 113 | 111 | |
39 | 2015 | Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia | YIN-KAI CHEN ; HSIN-AN HOU ; JIH-LUH TANG ; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; WEN-CHIEN CHOU ; Liu C.-Y.; CHUNG-WU LIN ; Chuang S.-S.; Chen, Chien-Yuan ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | PLoS ONE | 7 | 4 | |
40 | 2015 | High incidences of invasive fungal infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: A prospective observational study in Taiwan | JIH-LUH TANG ; HSIANG-CHI KUNG ; Lei W.-C.; MING YAO ; UN-IN WU ; SZU-CHUN HSU ; Lin C.-T.; Li C.-C.; SHANG-JU WU ; HSIN-AN HOU ; WEN-CHIEN CHOU ; SHANG-YI HUANG ; WOEI TSAY ; YAO-CHANG CHEN ; YEE-CHUN CHEN ; SHAN-CHWEN CHANG ; BOR-SHENG KO ; HWEI-FANG TIEN | PLoS ONE | 48 | 42 | |
41 | 2015 | Higher decorin levels in bone marrow plasma are associated with superior treatment response to novel agent-based induction in patients with newly diagnosed myeloma - A retrospective study | SHANG-YI HUANG ; Lin H.-H.; MING YAO ; JIH-LUH TANG ; SHANG-JU WU ; HSIN-AN HOU ; WEN-CHIEN CHOU ; SHENG-CHIEH CHOU ; SZU-CHUN HSU ; BOR-SHENG KO ; Lu H.-Y.; WOEI TSAY ; HWEI-FANG TIEN | PLoS ONE | 10 | 9 | |
42 | 2015 | GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution | HSIN-AN HOU ; YUN-CHU LIN ; Kuo Y.-Y.; WEN-CHIEN CHOU ; CHIEN-CHIN LIN ; Liu C.-Y.; Chen, Chien-Yuan ; LIANG-IN LIN ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Annals of Hematology | 21 | 20 | |
43 | 2014 | Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression | HSIN-AN HOU ; Kuo Y.-Y.; JIH-LUH TANG ; WEN-CHIEN CHOU ; MING YAO ; Lai Y.-J.; CHIEN-CHIN LIN ; Chen, Chien-Yuan ; Liu C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 58 | 54 | |
44 | 2014 | IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients | YI-TSUNG YANG ; HSIN-AN HOU ; Liu C.-Y.; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; Li C.-C.; Kuo Y.-Y.; SHANG-YI HUANG ; BOR-SHENG KO ; Chen, Chien-Yuan ; SZU-CHUN HSU ; Lin C.-T.; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 19 | 16 | |
45 | 2014 | SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution | CHIEN-CHIN LIN ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo Y.-Y.; SHANG-JU WU ; Liu C.-Y.; Chen, Chien-Yuan ; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; SZU-CHUN HSU ; BOR-SHENG KO ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 30 | 26 | |
46 | 2014 | The osteoblastogenesis potential of adipose mesenchymal stem cells in myeloma patients who had received intensive therapy | Lin H.-H.; Hwang S.-M.; SHANG-JU WU ; Hsu L.-F.; YI-HUA LIAO ; YI-SHUAN SHEEN ; Chuang W.-H.; SHANG-YI HUANG | PLoS ONE | 10 | 8 | |
47 | 2014 | Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia | HSIN-AN HOU ; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Liu C.-Y.; Chen, Chien-Yuan ; JIH-LUH TANG ; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; LIANG-IN LIN ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Leukemia | 77 | 73 | |
48 | 2014 | Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma | SHANG-YI HUANG ; CHUNG-WU LIN ; Lin H.-H.; MING YAO ; JIH-LUH TANG ; SHANG-JU WU ; YAO-CHANG CHEN ; Lu H.-Y.; HSIN-AN HOU ; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; WOEI TSAY ; Chou S.-J.; HWEI-FANG TIEN | Annals of Hematology | 53 | 48 | |
49 | 2014 | IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution | CHIEN-CHIN LIN ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo Y.-Y.; Liu C.-Y.; Chen, Chien-Yuan ; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 75 | 69 | |
50 | 2013 | Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression | SHANG-JU WU ; JIH-LUH TANG ; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; HSIN-AN HOU ; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; WOEI TSAY ; HWEI-FANG TIEN | American Journal of Hematology | 59 | 42 | |
51 | 2013 | Improving but Inferior Survival in Patients with Chronic Lymphocytic Leukemia in Taiwan: A Population-Based Study, 1990-2004 | SHANG-JU WU ; CHUN-JU CHIANG ; Lin C.-T.; HWEI-FANG TIEN ; Lai M.-S. | PLoS ONE | 18 | 19 | |
52 | 2012 | DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications | HSIN-AN HOU ; Kuo Y.-Y.; Liu C.-Y.; WEN-CHIEN CHOU ; Lee M.C.; Chen, Chien-Yuan ; LIANG-IN LIN ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood | 197 | 184 | |
53 | 2012 | The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution | SHANG-JU WU ; Kuo Y.-Y.; HSIN-AN HOU ; Li Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Lin C.-T.; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; JIH-LUH TANG ; WOEI TSAY ; HWEI-FANG TIEN | Blood | 124 | 100 | |
54 | 2011 | The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia | WEN-CHIEN CHOU ; Lei W.-C.; BOR-SHENG KO ; HSIN-AN HOU ; Chen C.-Y.; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Chang Y.-C.; KUAN-TING KUO ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Leukemia | 132 | 132 | |
55 | 2011 | TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics | WEN-CHIEN CHOU ; SHENG-CHIEH CHOU ; Liu C.-Y.; Chen, Chien-Yuan ; HSIN-AN HOU ; Kuo Y.-Y.; Lee M.-C.; BOR-SHENG KO ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Chang Y.-C.; Kuo Y.-Y.; KUAN-TING KUO ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 256 | 235 | |
56 | 2010 | EBV-positive Hodgkin lymphoma is associated with suppression of p21cip1/waf1 and a worse prognosis | Liu T.-Y.; SHANG-JU WU ; Huang M.-H.; Lo F.-Y.; Tsai M.-H.; CHING-HWA TSAI ; Hsu S.-M.; CHUNG-WU LIN | Molecular Cancer | 17 | 15 | |
57 | 2010 | The incidence of chronic lymphocytic leukemia in Taiwan, 1986-2005: A distinct increasing trend with birth-cohort effect | SHANG-JU WU ; SHANG-YI HUANG ; Lin C.-T.; Lin Jr. Y.; Chang C.-J.; HWEI-FANG TIEN | Blood | 56 | 48 | |
58 | 2010 | WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring system | HSIN-AN HOU ; TAI-CHUNG HUANG ; LIANG-IN LIN ; Liu C.-Y.; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; JIH-LUH TANG ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood | 142 | 137 | |
59 | 2010 | Minor histocompatibility antigen HA-1 and HA-2 polymorphisms in Taiwan: Frequency and application in hematopoietic stem cell transplantation | Lio H.-Y.; JIH-LUH TANG ; Wu J.; SHANG-JU WU ; Lin C.-Y.; YA-CHIEN YANG | Clinical Chemistry and Laboratory Medicine | 2 | 2 | |
60 | 2010 | Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations | WEN-CHIEN CHOU ; HUAI-HSUAN HUANG ; HSIN-AN HOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Chang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 176 | 160 | |
61 | 2010 | Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation | WEN-CHIEN CHOU ; HSIN-AN HOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Chang Y.-.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 181 | 173 | |
62 | 2009 | HLA-DR-matched parental donors for allogeneic hematopoietic stem cell transplantation in patients with high-risk acute leukemia | SHANG-JU WU ; MING YAO ; JIH-LUH TANG ; BOR-SHENG KO ; HWEI-FANG TIEN ; YAO-CHANG CHEN | Journal of the Formosan Medical Association | 2 | 2 | |
63 | 2009 | Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patients | WEN-CHIEN CHOU ; Chen, Chien-Yuan ; HSIN-AN HOU ; LIANG-IN LIN ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Leukemia | 55 | 51 | |
64 | 2009 | Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation | Wu J.; JIH-LUH TANG ; SHANG-JU WU ; Lio H.-Y.; YA-CHIEN YANG | Clinica Chimica Acta | 36 | 38 | |
65 | 2009 | Primary effusion lymphoma in three patients with chronic hepatitis B infection | SHANG-JU WU ; CHIEN-CHING HUNG ; CHIEN-HUNG CHEN ; HWEI-FANG TIEN | Journal of Clinical Virology | 15 | 11 | |
66 | 2009 | AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: Prognostic implication and interaction with other gene alterations | JIH-LUH TANG ; HSIN-AN HOU ; Chen, Chien-Yuan ; Liu C.-Y.; WEN-CHIEN CHOU ; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; LIANG-IN LIN ; HWEI-FANG TIEN | Blood | 284 | 255 | |
67 | 2008 | Clinical characteristics and treatment response of Hodgkin's lymphoma in Taiwan | SHANG-JU WU ; Chen, Chien-Yuan ; Su I.-J.; JIH-LUH TANG ; WEN-CHIEN CHOU ; BOR-SHENG KO ; Huang S.-Y.; MING YAO ; WOEI TSAY ; YAO-CHANG CHEN ; Wang C.-H.; HWEI-FANG TIEN | Journal of the Formosan Medical Association | 7 | 6 | |
68 | 2007 | RUNX1 gene mutation in primary myelodysplastic syndrome - The mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome | Chen, Chien-Yuan ; LIANG-IN LIN ; JIH-LUH TANG ; BOR-SHENG KO ; WOEI TSAY ; WEN-CHIEN CHOU ; MING YAO ; SHANG-JU WU ; Tseng M.-H.; HWEI-FANG TIEN | British Journal of Haematology | 115 | 106 | |
69 | 2007 | Severe pulmonary complications after initial treatment with rituximab for the Asian-variant of intravascular lymphoma | SHANG-JU WU ; WEN-CHIEN CHOU ; BOR-SHENG KO ; HWEI-FANG TIEN | Haematologica | 29 | 30 | |
70 | 2007 | Anaplastic large cell lymphoma in leukemic transformation: Successful treatment by transplantation | SHANG-JU WU ; MING YAO ; HWEI-FANG TIEN ; JIH-LUH TANG ; CHUNG-WU LIN ; YAO-CHANG CHEN | Journal of Clinical Oncology | 2 | 1 | |
71 | 2007 | Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations | WEN-CHIEN CHOU ; JIH-LUH TANG ; SHANG-JU WU ; WOEI TSAY ; MING YAO ; SHANG-YI HUANG ; KUO-CHIN HUANG ; Chen, Chien-Yuan ; Huang C.-F.; HWEI-FANG TIEN | Leukemia | 94 | 90 | |
72 | 2006 | Clinical implications of SOCS1 methylation in myelodysplastic syndrome | SHANG-JU WU ; MING YAO ; WEN-CHIEN CHOU ; JIH-LUH TANG ; Chen, Chien-Yuan ; BOR-SHENG KO ; Huang S.-Y.; WOEI TSAY ; YAO-CHANG CHEN ; MING-CHING SHEN ; Wang C.-H.; Yeh Y.-C.; HWEI-FANG TIEN | British Journal of Haematology | 35 | 29 | |
73 | 2006 | Nucleophosmin mutations in de novo acute myeloid leukemia: The age-dependent incidences and the stability during disease evolution | WEN-CHIEN CHOU ; JIH-LUH TANG ; LIANG-IN LIN ; MING YAO ; WOEI TSAY ; Chen, Chien-Yuan ; SHANG-JU WU ; Huang C.-F.; Chiou R.-J.; Tseng M.-H.; Lin D.-T.; Lin K.-H.; YAO-CHANG CHEN ; HWEI-FANG TIEN | Cancer Research | 151 | 139 |